Skip to main content

Overview

Skip to main content

Presentation Details

Overview

Presentation Details

GILD HIV Analyst & Investor Event

December 13, 2024

View this Presentation PDF Format Download (opens in new window) PDF 6.13 MB Listen to this Presentation Audio Format Download (opens in new window) Watch this Presentation Video Format Download (opens in new window) View this Presentation PDF Format Download (opens in new window)

IR Contact

Gilead Investor Relations

(650) 574-3000
investor_relations@gilead.com

Follow Us

Twitter
LinkedIn
Instagram
Facebook
YouTube

Investor Email Alerts

To opt-in for investor email alerts, please:

Enter your email address in the field below and select at least one alert option.
After submitting your request, you will receive an activation email to the requested email address.
You must click the activation link in order to complete your subscription.

At Gilead, we promise to treat your data with respect. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Gilead to send you the requested Investor Email Alert updates.

* Required

By registering to receive Investor Email Alert updates, you confirm you have read our Privacy Notice. Email Address *

Investor Alert Options

Investor Alert Options *

News

Quarterly Reports

SEC Filings

End of Day Stock Quote

Events & Presentations

Unsubscribe

Email Alert Sign Up Confirmation

Terms of Use
Privacy Policy
Consumer Health Data Privacy Policy
Cookies Policy
Investor Disclaimer

© 1996-2023 Gilead Sciences, Inc. All rights reserved.

Powered By Q4 Inc. 5.168.1.2 (opens in new window)